Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × IFL protocol × Clear all

Phase

Status

Completed 10 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Margins of Excision 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1

Interventions

Capecitabine 24 Oxaliplatin 22 Radiotherapy 15 Fluorouracil 13 Surgical Procedures, Operative 11 Drug Therapy 8 Chemoradiotherapy 8 Bevacizumab 8 Leucovorin 7 Consolidation Chemotherapy 7 Radiation 6 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 sintilimab 4 Neoadjuvant Therapy 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3 Cyclophosphamide 3 Cetuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡